A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.